IRTC

IRTC

USD

iRhythm Technologies Inc. Common Stock

$181.100-1.580 (-0.865%)

السعر في الوقت الحقيقي

Healthcare
الأجهزة الطبية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$182.680

الأعلى

$185.040

الأدنى

$177.740

الحجم

0.37M

أساسيات الشركة

القيمة السوقية

5.8B

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

0.40M

البورصة

NMS

العملة

USD

نطاق 52 أسبوعاً

الأدنى $71الحالي $181.100الأعلى $212

أخبار ذات صلة

GlobeNewswire

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today

عرض المزيد
iRhythm Technologies to Participate in Upcoming Investor Conferences
Analyst Upgrades

Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies with a Buy and raises the price target from $193 to $212.

عرض المزيد
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212
Analyst Upgrades

Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies with a Buy and raises the price target from $205 to $242.

عرض المزيد
Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242
Analyst Upgrades

JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240

JP Morgan analyst Allen Gong maintains iRhythm Technologies with a Overweight and raises the price target from $190 to $240.

عرض المزيد
JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240
Analyst Upgrades

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets.

عرض المزيد
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
Analyst Upgrades

Goldman Sachs Maintains Neutral on iRhythm Technologies, Raises Price Target to $202

Goldman Sachs analyst David Roman maintains iRhythm Technologies with a Neutral and raises the price target from $180 to $202.

Analyst Upgrades

Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $244

Needham analyst David Saxon maintains iRhythm Technologies with a Buy and raises the price target from $193 to $244.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.